East Asian-specific and cross-ancestry genome-wide meta-analyses provide mechanistic insights into peptic ulcer disease

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We want to acknowledge all the participants and investigators of BioBank Japan, Tohoku Medical Megabank, UK Biobank, and FinnGen. We express our gratitude to Prof. Mark Lathrop for his valuable support. This research was supported by the Ministry of Education, Culture, Sports, Sciences and Technology (MEXT) of Japanese government and the Japan Agency for Medical Research and Development (AMED) under grant numbers JP21km0605001 (the BioBank Japan project), JP15km0105004 and JP21tm0124006 (the Tohoku Medical Megabank Project, Special Account for the Reconstruction of the Great East Japan Earthquake), JP20km0405001 (for the supercomputer resource), and JP21km0405215 (to C.T., K.M., and Y.K.). We thank the Human Genome Center, the Institute of Medical Science, the University of Tokyo for providing the super-computing resource used in this study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethics committees at the Institute of Medical Science, the University of Tokyo (application number 29-74-A0215), and Iwate Tohoku Medical Megabank Organization, Iwate Medical University (application number HG H25-2) approved this research project.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes